“Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor” (2024) Iranian Journal of Kidney Diseases, 18(2), pp. 108–117. doi:10.5254/0n3xpz60.